Cargando…
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment
To identify liquid biomarkers that predict clinical outcomes of epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI), we enrolled patients with EGFR gene mutation‐positive non–small‐cell lung cancer who were intended to receive gefitinib treatment. Using plasma samples obtained prio...
Autores principales: | Ochiai, Ryosuke, Hayashi, Kentaro, Yamamoto, Hiroshi, Fujii, Risa, Saichi, Naomi, Shinchi, Hiroki, Ishida, Tsuyoshi, Honda, Takeshi, Shimizu, Tetsuo, Matsutani, Noriyuki, Seki, Nobuhiko, Kawamura, Masafumi, Ueda, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633313/ https://www.ncbi.nlm.nih.gov/pubmed/36028467 http://dx.doi.org/10.1111/cas.15512 |
Ejemplares similares
-
Role of Dok-1 and Dok-2 in Leukemia Suppression
por: Niki, Masaru, et al.
Publicado: (2004) -
Role of Dok-1 and Dok-2 in Myeloid Homeostasis and Suppression of Leukemia
por: Yasuda, Tomoharu, et al.
Publicado: (2004) -
Immunological effect of local ablation combined with immunotherapy on solid malignancies
por: Takahashi, Yusuke, et al.
Publicado: (2017) -
Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling
por: Shinohara, Hisaaki, et al.
Publicado: (2005) -
Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes
por: Ueda, Koji, et al.
Publicado: (2014)